Aerovance, Inc.

Quick facts

Phase 2 pipeline

• AER 001 · Respiratory
  AER 001 is an investigational monoclonal antibody targeting IL-13.
• Aerovant · Other

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Aerovance, Inc. portfolio CI brief
• Aerovance, Inc. pipeline updates RSS